Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
1(17%)
Results Posted
100%(1 trials)
Terminated
2(33%)

Phase Distribution

Ph phase_3
1
17%
Ph phase_1
1
17%
Ph not_applicable
2
33%
Ph phase_2
1
17%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

20.0%

1 of 5 finished

Non-Completion Rate

80.0%

4 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(1)
Terminated(4)

Detailed Status

Terminated2
Withdrawn2
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
33.3%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
N/A2 (40.0%)

Trials by Status

terminated233%
withdrawn233%
completed117%
recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
recruitingnot_applicable

Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?

NCT04859218
withdrawn

Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis

NCT04921696
terminatednot_applicable

Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery

NCT01866657
terminatedphase_1

Red Blood Cell Transfusion in Patients With Coronary Artery Disease (CAD)

NCT01504945
completedphase_3

RBC Transfusion in Severe Anemia With Lactic Acidosis

NCT01586923
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04859218Not Applicable

Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?

Recruiting
NCT04921696

Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis

Withdrawn
NCT01866657Not Applicable

Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery

Terminated
NCT01504945Phase 1

Red Blood Cell Transfusion in Patients With Coronary Artery Disease (CAD)

Terminated
NCT01586923Phase 3

RBC Transfusion in Severe Anemia With Lactic Acidosis

Completed
NCT00850369Phase 2

A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension

Withdrawn

All 6 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
6